-
Microwave ablation combined with PD-L1 blockade synergistically promotes Cxcl9-mediated antitumor immunity Cancer Sci. (IF 5.7) Pub Date : 2024-04-24 Ningning He, Hao Huang, Shaoxian Wu, Weipeng Ji, Yicheng Tai, Ruicheng Gao, Yingting Liu, Yungang Liu, Lujun Chen, Dawei Zhu, Xiao Zheng, Jingting Jiang
-
USP3: Key deubiquitylation enzyme in human diseases Cancer Sci. (IF 5.7) Pub Date : 2024-04-23 Hongyan Zhang, Wenjing Liu, Yingying Wu, Ceshi Chen
Ubiquitination and deubiquitylation are pivotal posttranslational modifications essential for regulating cellular protein homeostasis and are implicated in the development of human diseases. Ubiquitin-specific protease 3 (USP3), a member of the ubiquitin-specific protease family, serves as a key deubiquitylation enzyme, playing a critical role in diverse cellular processes including the DNA damage
-
Adaptive use of error-prone DNA polymerases provides flexibility in genome replication during tumorigenesis Cancer Sci. (IF 5.7) Pub Date : 2024-04-23 Lewis J. Bainbridge, Yasukazu Daigaku
-
The LAT1 inhibitor JPH203 suppresses the growth of castration‐resistant prostate cancer through a CD24‐mediated mechanism Cancer Sci. (IF 5.7) Pub Date : 2024-04-24 Shinpei Saito, Keisuke Ando, Shinichi Sakamoto, Minhui Xu, Yasutaka Yamada, Junryo Rii, Sanji Kanaoka, Jiaxing Wei, Xue Zhao, Sangjon Pae, Manato Kanesaka, Yusuke Goto, Tomokazu Sazuka, Yusuke Imamura, Yoshie Reien, Norie Hamaguchi‐Suzuki, Shota Saito, Yuri Hirayama, Hirofumi Hashimoto, Yoshikatsu Kanai, Tomohiko Ichikawa, Naohiko Anzai
L‐type amino acid transporter 1 (LAT1) is specifically expressed in many malignancies, contributes to the transport of essential amino acids, such as leucine, and regulates the mammalian target of rapamycin (mTOR) signaling pathway. We investigated the expression profile and functional role of LAT1 in prostate cancer using JPH203, a specific inhibitor of LAT1. LAT1 was highly expressed in castration‐resistant
-
Senescence and senolysis in cancer: The latest findings Cancer Sci. (IF 5.7) Pub Date : 2024-04-19 Yoshimi Imawari, Makoto Nakanishi
-
Efficacy and biomarker analysis of second-line nab-paclitaxel plus sintilimab in patients with advanced biliary tract cancer Cancer Sci. (IF 5.7) Pub Date : 2024-04-18 Xiaofen Li, Nan Zhou, Yu Yang, Zijian Lu, Hongfeng Gou
-
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-04-18 Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
-
EZH2 suppresses ferroptosis in hepatocellular carcinoma and reduces sorafenib sensitivity through epigenetic regulation of TFR2 Cancer Sci. (IF 5.7) Pub Date : 2024-04-16 Yongwei Lai, Xu Han, Bo Xie, Yan Xu, Zhengyi Yang, Didi Wang, Wei Li, Yaohong Xie, Wenqi Song, Xiaohong Zhang, Jia Qi Xia, Pengxia Zhang
-
Clonal expansion in normal tissues Cancer Sci. (IF 5.7) Pub Date : 2024-04-16 Hirona Maeda, Nobuyuki Kakiuchi
-
Pyroptotic macrophages promote proliferation and chemotherapy resistance of peripheral T‐cell lymphoma via TLR4 signaling pathway Cancer Sci. (IF 5.7) Pub Date : 2024-04-13 Han Zhang, Liru Li, Zijian Zhang, Shiqi Gao, Mingzhe Yang, Wenjie Ma, Hongbin Li, Wenhui Zhao, Huike Yang, Yue Zhang, Shu Zhao
-
Radiosensitizing effect of a novel CTSS inhibitor by enhancing BRCA1 protein stability in triple‐negative breast cancer cells Cancer Sci. (IF 5.7) Pub Date : 2024-04-13 Eun Choi, Kyung‐Hwa Jeon, Hanhee Lee, Gil‐Im Mun, Jeong‐Ahn Kim, Jae‐Ho Shin, Youngjoo Kwon, Younghwa Na, Yun‐Sil Lee
-
ECM1 and KRT6A are involved in tumor progression and chemoresistance in the effect of dexamethasone on pancreatic cancer Cancer Sci. (IF 5.7) Pub Date : 2024-04-13 Yoshiki Shinomiya, Yusuke Kouchi, Sakurako Harada‐Kagitani, Takayuki Ishige, Shigetsugu Takano, Masayuki Ohtsuka, Jun‐Ichiro Ikeda, Takashi Kishimoto
-
Time trend analysis of rare cancer incidence 2011–2018: Nationwide population‐based cancer registries in Japan Cancer Sci. (IF 5.7) Pub Date : 2024-04-13 Hiromi Sugiyama, Manami Konda, Kumiko Saika, Tomohiro Matsuda
-
-
Antiapoptotic PON2 expression and its clinical implications in locally advanced oral squamous cell carcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-04-11 Mehta Vedant Kamal, Rama Rao Damerla, Preetiparna Parida, Sanjiban Chakrabarty, Mahadev Rao, Naveena AN Kumar
-
In this issue Cancer Sci. (IF 5.7) Pub Date : 2024-04-11
Blueprints from plane to space: outlook of next-generation three-dimensional histopathology Traditionally, the diagnosis for several diseases is either suspected or confirmed by viewing thin tissue sections under a microscope to spot signature manifestations of a disease, known as clinical histopathology. While this provides a 2D representation of the tissue structure, it does not capture the inherent
-
Cytosolic DNA sensor AIM2 promotes KRAS‐driven lung cancer independent of inflammasomes Cancer Sci. (IF 5.7) Pub Date : 2024-04-10 Mohammad Alanazi, Teresa Weng, Louise McLeod, Linden J. Gearing, Julian A. Smith, Beena Kumar, Mohamed I. Saad, Brendan J. Jenkins
-
Prognostic effect of TCF1+ CD8+ T cell and TOX+ CD8+ T cell infiltration in lung adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-04-09 Yao Wang, Lin Ma, Yu Chen, Wenhua Yun, Jinming Yu, Xiangjiao Meng
-
IGSF3 is a homophilic cell adhesion molecule that drives lung metastasis of melanoma by promoting adhesion to vascular endothelium Cancer Sci. (IF 5.7) Pub Date : 2024-04-09 Yue Guo, Yutaka Kasai, Yuto Tanaka, Yuki Ohashi‐Kumagai, Takeharu Sakamoto, Takeshi Ito, Yoshinori Murakami
-
A new tandem repeat‐enriched lncRNA XLOC_008672 promotes gastric carcinogenesis by regulating G3BP1 expression Cancer Sci. (IF 5.7) Pub Date : 2024-04-06 Li Li, Shijun Yu, Ning Dou, Xiao Wang, Yong Gao, Yandong Li
-
Development and validation of a radiosensitivity model to evaluate radiotherapy benefits in pan‐cancer Cancer Sci. (IF 5.7) Pub Date : 2024-04-04 Qi Yang, Xinyi Zhou, Jianbo Fang, Anqi Lin, Hongman Zhang, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang
-
Rev1 overexpression accelerates N‐methyl‐N‐nitrosourea (MNU)‐induced thymic lymphoma by increasing mutagenesis Cancer Sci. (IF 5.7) Pub Date : 2024-04-04 Megumi Sasatani, Yang Xi, Kazuhiro Daino, Atsuko Ishikawa, Yuji Masuda, Junko Kajimura, Jinlian Piao, Elena Karamfilova Zaharieva, Hiroaki Honda, Guanyu Zhou, Kanya Hamasaki, Yoichiro Kusunoki, Tsutomu Shimura, Shizuko Kakinuma, Yoshiya Shimada, Kazutaka Doi, Tomoko Ishikawa‐Fujiwara, Yusuke Sotomaru, Kenji Kamiya
-
Decreased risk of renal cell carcinoma in patients with type 2 diabetes treated with sodium glucose cotransporter‐2 inhibitors Cancer Sci. (IF 5.7) Pub Date : 2024-04-04 Chun‐Huei Chiu, Wei‐Yao Wang, Hung‐Yi Chen, Pei‐Lun Liao, Gwo‐Ping Jong, Tsung‐Yuan Yang
-
YTHDC1‐dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple‐negative breast cancer Cancer Sci. (IF 5.7) Pub Date : 2024-04-03 Xi Shen, Jianxin Zhong, Pan Yu, Feng Liu, Haoran Peng, Nianyong Chen
-
Downregulation of ABCC3 activates MAPK signaling through accumulation of deoxycholic acid in colorectal cancer cells Cancer Sci. (IF 5.7) Pub Date : 2024-04-03 Yukihiro Sato, Minoru Kobayashi, Masahiro Ohira, Ryo Funayama, Masamitsu Maekawa, Hideaki Karasawa, Ryosuke Kashiwagi, Yayoi Aoyama, Nariyasu Mano, Shinobu Ohnuma, Michiaki Unno, Keiko Nakayama
-
PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis Cancer Sci. (IF 5.7) Pub Date : 2024-04-03 Song Wang, Yueyao Zhang, Dan Zhang, Jie Meng, Na Che, Xiulan Zhao, Tieju Liu
-
Long noncoding RNATUG1 promotes cisplatin resistance in ovarian cancer via upregulation of DNA polymerase eta Cancer Sci. (IF 5.7) Pub Date : 2024-04-01 Ryosuke Sonobe, Peng Yang, Miho M. Suzuki, Keiko Shinjo, Kenta Iijima, Nobuhiro Nishiyama, Kanjiro Miyata, Kazunori Kataoka, Hiroaki Kajiyama, Yutaka Kondo
-
Application of prime editing system to introduce TP53 R248Q hotspot mutation in acute lymphoblastic leukemia cell line Cancer Sci. (IF 5.7) Pub Date : 2024-03-29 Thao Nguyen, Tomomi Aida, Yuka Iijima‐Yamashita, Minori Tamai, Akiko Nagamachi, Keiko Kagami, Chiaki Komatsu, Shin Kasai, Koshi Akahane, Kumiko Goi, Toshiya Inaba, Masashi Sanada, Takeshi Inukai
-
Identification of barriers to implementation of precision oncology in patients with rare cancers Cancer Sci. (IF 5.7) Pub Date : 2024-03-28 Shigemasa Takamizawa, Takafumi Koyama, Kuniko Sunami, Kazuki Sudo, Makoto Hirata, Takashi Kubo, Kayoko Tao, Hourin Cho, Yoshitaka Narita, Ken Kato, Naoya Yamazaki, Yuichiro Ohe, Takuji Okusaka, Yoshiyuki Matsui, Chitose Ogawa, Kan Yonemori, Noboru Yamamoto
-
Expression of Concern: Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species‐dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance Cancer Sci. (IF 5.7) Pub Date : 2024-03-28
Expression of Concern: Chakraborty, J.B., Mahato, S.K., Joshi, K., Shinde, V., Rakshit, S., Biswas, N., Choudhury (Mukherjee), I., Mandal, L., Ganguly, D., Chowdhury, A.A., Chaudhuri, J., Paul, K., Pal, B.C., Vinayagam, J., Pal, C., Manna, A., Jaisankar, P., Chaudhuri, U., Konar, A., Roy, S. and Bandyopadhyay, S. (2012), Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells
-
Impacts of tissue context on extracellular vesicles‐mediated cancer–host cell communications Cancer Sci. (IF 5.7) Pub Date : 2024-03-27 Nao Nishida‐Aoki, Takahiro Ochiya
-
Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-27 Takafumi Nakano, Seiichiro Takao, Katsushi Dairaku, Naoki Uno, Siew‐Kee (Amanda) Low, Masahiro Hashimoto, Yasuo Tsuda, Yuichi Hisamatsu, Takeo Toshima, Yusuke Yonemura, Takaaki Masuda, Ken Eto, Toru Ikegami, Yosuke Fukunaga, Atsushi Niida, Satoshi Nagayama, Koshi Mimori
-
Microsatellite instability: A 2024 update Cancer Sci. (IF 5.7) Pub Date : 2024-03-26 Hiroyuki Yamamoto, Yoshiyuki Watanabe, Hiroyuki Arai, Kumiko Umemoto, Keisuke Tateishi, Yu Sunakawa
-
Cancer‐specific risk prediction with a serum microRNA signature Cancer Sci. (IF 5.7) Pub Date : 2024-03-25 Janhavi R. Raut, Megha Bhardwaj, Ben Schöttker, Bernd Holleczek, Petra Schrotz‐King, Hermann Brenner
We recently derived and validated a serum‐based microRNA risk score (miR‐score) that predicted colorectal cancer (CRC) occurrence with very high accuracy within 14 years of follow‐up in a population‐based cohort study from Germany (ESTHER cohort). Here, we aimed to evaluate associations of the CRC‐specific miR‐score with the risk of developing other common cancers, including female breast cancer (BC)
-
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments Cancer Sci. (IF 5.7) Pub Date : 2024-03-25 Hironori Fukuda, Kosuke Arai, Hideaki Mizuno, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Toru Maruyama, Kenta Kuwabara, Takashi Nishizawa, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun‐ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi
-
WTAP-induced N6-methyladenosine of PD-L1 blocked T-cell-mediated antitumor activity under hypoxia in colorectal cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-20 Qi-zhi Liu, Nan Zhang, Jun-yi Chen, Min-jun Zhou, De-hua Zhou, Zhuo Chen, Zhen-xing Huang, Yu-xiang Xie, Guang-lei Qiao, Xiao-huang Tu
-
Correction to: Phytochemical library screening reveals betulinic acid as a novel Skp2‐SCF E3 ligase inhibitor in non–small cell lung cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-20
He D-H, Chen Y-F, Zhou Y-L, et al. Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non–small cell lung cancer. Cancer Sci. 2021;112: 3218–3232. https://doi.org/10.1111/cas.15005 In Figure 2, there were errors in the images (the boundaries of the bands are not smooth). The correct images (unmodified original blots) are shown below: Figure 2C. Skp1 blot
-
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma Cancer Sci. (IF 5.7) Pub Date : 2024-03-18 Yasuo Mori, Jun Takizawa, Yuna Katsuoka, Naoki Takezako, Koji Nagafuji, Hiroshi Handa, Junya Kuroda, Kazutaka Sunami, Tomohiko Kamimura, Ryosuke Ogawa, Yoshikane Kikushige, Mine Harada, Koichi Akashi, Toshihiro Miyamoto
-
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-18 Masahiro Hashimoto, Takaaki Masuda, Yusuke Nakano, Taro Tobo, Hideyuki Saito, Kensuke Koike, Junichi Takahashi, Tadashi Abe, Yuki Ando, Yuki Ozato, Kiyotaka Hosoda, Satoshi Higuchi, Yuichi Hisamatsu, Takeo Toshima, Yusuke Yonemura, Tsuyoshi Hata, Mamoru Uemura, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Koshi Mimori
-
Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer‐associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p‐ACLY axis Cancer Sci. (IF 5.7) Pub Date : 2024-03-18 Pan Liu, Yue Wang, Xiang Li, Zhenan Liu, Yunqing Sun, Hanzhe Liu, Zhe Shao, Erhui Jiang, Xiaocheng Zhou, Zhengjun Shang
-
Correction to “Role of tumor necrosis factor‐α and its receptors in human benign breast lesions and tumors (in situ and infiltrative)” Cancer Sci. (IF 5.7) Pub Date : 2024-03-18
García-Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R. and Royuela, M. (2006), Role of tumor necrosis factor-α and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Science, 97: 1044–1049. https://doi.org/10.1111/j.1349-7006.2006.00277.x The Western blot bands in Figure 1 were cropped and pasted into a standard background. This type of image processing
-
Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-15 Zhuo Cheng, Cheng Yang, Qian Zhao, Jingjiao Zhong, Jin Zhang, Riming Jin, Yao Li, Na Ta, Dong Wu, Zhengang Yuan, Wen Sun, Ruoyu Wang
-
Upregulation of HLA‐II related to LAG‐3+CD4+ T cell infiltration is associated with patient outcome in human glioblastoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Wenli Guo, Daijun Peng, Yuee Liao, Lei Lou, Moran Guo, Chen Li, Wangyang Yu, Xiaoxi Tian, Guohui Wang, Ping Lv, Jing Zuo, Haitao Shen, Yuehong Li
-
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Zhiduan Cai, Wenjun Luo, Haoran Wang, Rui Zhu, Yaoji Yuan, Xiangyu Zhan, Mengyuan Xie, Haoquan Zhuang, Haoyu Chen, Yuyu Xu, Xiezhao Li, Leyuan Liu, Guibin Xu
-
Alix‐normalized exosomal programmed death‐ligand 1 analysis in urine enables precision monitoring of urothelial cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Hyun‐Kyung Woo, Juhee Park, Kyung Hwan Kim, Ja Yoon Ku, Hong Koo Ha, Yoon‐Kyoung Cho
-
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Haruna Fujimori, Mao Shima‐Nakamura, Shin‐Ichiro Kanno, Rie Shibuya‐Takahashi, Mai Mochizuki, Masamichi Mizuma, Michiaki Unno, Yuta Wakui, Makoto Abue, Wataru Iwai, Daisuke Fukushi, Kennich Satoh, Kazunori Yamaguchi, Norihisa Shindo, Jun Yasuda, Keiichi Tamai
-
Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Xundong Wei, Lei Wang, Bing Yang, Yuanyuan Ma, Wei Yuan, Jie Ma
-
Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Paula Duch, Natalia Díaz‐Valdivia, Marta Gabasa, Rafael Ikemori, Marselina Arshakyan, Patricia Fernández‐Nogueira, Alejandro Llorente, Cristina Teixido, Josep Ramírez, Javier Pereda, Lourdes Chuliá‐Peris, José Marcelo Galbis, Frank Hilberg, Noemí Reguart, Derek C. Radisky, Jordi Alcaraz
-
Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Meiru Chen, Jinghan Ma, Xiaoli Xie, Miao Su, Dongqiang Zhao
-
KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Kazuya Kato, Takehiro Noda, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Mamoru Uemura, Tadafumi Asaoka, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
-
LncRNA CTBP1‐AS inhibits TP63‐mediated activation of S100A14 during prostate cancer progression Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Guangzheng Wu, Zhenkun Dong, Yuhang Dong, Yinmei Chen, Huan Zhu, Dexin Ding, Yan Cui, Yiwen Wang, Yangyang Xu, Hui Chen
-
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Jee Soo Park, Hongkyung Kim, Won Sik Jang, Jongchan Kim, Won Sik Ham, Seung‐Tae Lee
-
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
-
RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells Cancer Sci. (IF 5.7) Pub Date : 2024-03-12 Linxiang Gong, Dominic Chih‐Cheng Voon, Joji Nakayama, Chiaki Takahashi, Susumu Kohno
-
-
In this issue Cancer Sci. (IF 5.7) Pub Date : 2024-03-08
Anti-angiogenesis in colorectal cancer therapy Colorectal cancer (CRC) is the third most common type of cancer worldwide, making it a significant health concern. This type of cancer generally begins with the abnormal growth of cells in the colon or rectum and may eventually transform to a malignant cancer that spreads to other organs. The key to the progression of CRC lies in a process called angiogenesis
-
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-07 Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
-
Serum and tissue metallome of pancreatic ductal adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Sooin Byeon, Taymin du Toit-Thompson, Luke Hipperson, Sarah Maloney, Ross Wenzel, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni
-
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression Cancer Sci. (IF 5.7) Pub Date : 2024-03-05 Zhenyu Zhou, Zheng Chen, Qianlei Zhou, Shiyu Meng, Juanyi Shi, Sintim Mui, Hai Jiang, Jianhong Lin, Gui He, Wenbin Li, Jianlong Zhang, Jie Wang, Chuanchao He, Yongcong Yan, Zhiyu Xiao
-
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi